Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Rothman

Showing results (151-160 of 262) with videos related to

Pageof 27
Sort By:
The American Journal of Cardiology|April 12, 2000
Chronic treatment with phentermine combined with fenfluramine lowers plasma serotoninR B Rothman, J B Redmon, S K Raatz, et al.
Neuropeptides|May 1, 1984
Ionic conditions differentially affect 3H-DADL binding to type-I and type-II opiate delta receptors in vitroR B Rothman, J A Danks, C B Pert, et al.
Neuropeptides|June 1, 1984
Tritiated-6-beta-fluoro-6-desoxy-oxymorphone: a highly selective ligand for the opiate mu receptor whose binding is characterized by low nonspecific bindingR B Rothman, J A Danks, A E Jacobson, et al.
Peptides|March 1, 1990
Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brainR B Rothman, V Bykov, B R de Costa, et al.
Progress in Clinical and Biological Research|January 1, 1990
Evidence for four opioid kappa binding sites in guinea pig brainR B Rothman, V Bykov, B R de Costa, et al.
Synapse (New York, N.Y.)|February 5, 2000
Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuseR B Rothman, J S Partilla, M H Baumann, et al.
Journal of Medicinal Chemistry|April 28, 1995
Enantiomers of diastereomeric cis-N-[1-(2-hydroxy-2-phenylethyl)- 3-methyl-4-piperidyl]-N-phenylpropanamides: synthesis, X-ray analysis, and biological activitiesG A Brine, P A Stark, Y Liu, et al.
Brain Research. Molecular Brain Research|May 13, 1999
Region-specific up-regulation of opioid receptor binding in enkephalin knockout miceL S Brady, M Herkenham, R B Rothman, et al.
Synapse (New York, N.Y.)|February 1, 1995
6 beta-[125iodo]-3, 14-dihydroxy-17-methyl-4, 5 alpha-epoxymorphinan ([125I]IOXY-AGO): a potent and selective radioligand for opioid mu receptorsH Xu, C B Goodman, J S Partilla, et al.
Peptides|January 1, 1994
Low affinity of FMRFamide and four FaRPs (FMRFamide-related peptides), including the mammalian-derived FaRPs F-8-Famide (NPFF) and A-18-Famide, for opioid mu, delta, kappa 1, kappa 2a, or kappa 2b receptorsR B Raffa, A Kim, K C Rice, et al.
Pageof 27

Showing results (151-160 of 262) with videos related to

Sort By:
Pageof 27
The American Journal of Cardiology|April 12, 2000
Chronic treatment with phentermine combined with fenfluramine lowers plasma serotoninR B Rothman, J B Redmon, S K Raatz, et al.
Neuropeptides|May 1, 1984
Ionic conditions differentially affect 3H-DADL binding to type-I and type-II opiate delta receptors in vitroR B Rothman, J A Danks, C B Pert, et al.
Neuropeptides|June 1, 1984
Tritiated-6-beta-fluoro-6-desoxy-oxymorphone: a highly selective ligand for the opiate mu receptor whose binding is characterized by low nonspecific bindingR B Rothman, J A Danks, A E Jacobson, et al.
Peptides|March 1, 1990
Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brainR B Rothman, V Bykov, B R de Costa, et al.
Progress in Clinical and Biological Research|January 1, 1990
Evidence for four opioid kappa binding sites in guinea pig brainR B Rothman, V Bykov, B R de Costa, et al.
Synapse (New York, N.Y.)|February 5, 2000
Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuseR B Rothman, J S Partilla, M H Baumann, et al.
Journal of Medicinal Chemistry|April 28, 1995
Enantiomers of diastereomeric cis-N-[1-(2-hydroxy-2-phenylethyl)- 3-methyl-4-piperidyl]-N-phenylpropanamides: synthesis, X-ray analysis, and biological activitiesG A Brine, P A Stark, Y Liu, et al.
Brain Research. Molecular Brain Research|May 13, 1999
Region-specific up-regulation of opioid receptor binding in enkephalin knockout miceL S Brady, M Herkenham, R B Rothman, et al.
Synapse (New York, N.Y.)|February 1, 1995
6 beta-[125iodo]-3, 14-dihydroxy-17-methyl-4, 5 alpha-epoxymorphinan ([125I]IOXY-AGO): a potent and selective radioligand for opioid mu receptorsH Xu, C B Goodman, J S Partilla, et al.
Peptides|January 1, 1994
Low affinity of FMRFamide and four FaRPs (FMRFamide-related peptides), including the mammalian-derived FaRPs F-8-Famide (NPFF) and A-18-Famide, for opioid mu, delta, kappa 1, kappa 2a, or kappa 2b receptorsR B Raffa, A Kim, K C Rice, et al.
Pageof 27